Depression, Coronary Artery Disease
Conditions
Keywords
Coronary artery disease, depression, psychotherapy, randomized controlled trial
Brief summary
In patients with coronary artery disease (CAD), depressive symptoms are frequent and highly relevant for quality of life, health behaviour, health care costs, and prognosis. The aim of the current study is to evaluate the effects of a psychotherapy intervention on symptoms of depression in patients with CAD. Therefore, depressed patients diagnosed with CAD will be randomised into a controlled intervention trial, comparing a stepwise psychotherapy intervention with usual cardiological care. The manualized psychotherapy intervention starts with three individual sessions offered on a weekly basis. Afterwards, symptoms of depression will be re-evaluated and, in case of persisting symptoms, patients receive an additional 25 sessions of psychodynamic group psychotherapy over a total period of one year. The psychodynamic approach was chosen in order to specifically take into account personality traits such as negative affectivity and social inhibition, the components of the Type D personality, which may explain why recent cognitive behavioural psychotherapy (CBT) trials produced only small effects in depressed CAD patients. The investigators expect that the intervention will reduce depressive symptoms as well as the prevalence of depressive disorders. It will also improve both behaviourally and physiologically mediated cardiovascular risk indicators, promote better quality of life, and reduce healthcare costs. Subgroup analyses will be performed in order to identify gender-specific treatment effects, effects on immunological stress reactivity, and genetic predictors of treatment success.
Interventions
Stepwise, manualized individual and group psychotherapy in addition to usual cardiological care.
One information session about living with heart disease.
Usual cardiological care
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with coronary artery disease * German speaking men and women * Recent coronary angiogram (\<= 3 months old) * Depression score (HADS-D) \>= 8 * Written informed consent
Exclusion criteria
* Severe heart failure * Other acutely life- threatening conditions * Severe chronic inflammatory disease * Current suicidal tendency * Severe depressive episode * Other severe mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes from baseline to 18 months in depressive symptoms (HADS-D) | 18 months |
Secondary
| Measure | Time frame |
|---|---|
| Health-related quality of life (SF36, EuroQuol-5D) | 18 months |
| cardiovascular risk profile | 18 months |
| neuroendocrine and immunological activation | 18 months |
| Remission of depressive disorder (SCID) and the Type D pattern (DS-14), reduced severity of depressive symptoms (HAM-D) | 18 months |
| heart rate variability | 18 months |
| cardiac events | 18 months |
| health care utilisation and costs | 18 months |
| coagulation | 18 months |
Countries
Germany